PWPS
BBIO icon

Pinnacle Wealth Planning Services’s BridgeBio Pharma BBIO Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2K Sell
781
-6
-0.8% -$420 0.01% 1167
2026
Q1 		$58.4K Hold
787
– – 0.01% 1110
2025
Q4 		$60.2K Buy
+787
New +$51.7K 0.01% 1075
2021
Q1 		– Sell
-647
Closed -$46K – 508
2020
Q4 		$46K Buy
+647
New +$31.2K 0.01% 834

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Pinnacle Wealth Planning Services's BBIO Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its BridgeBio Pharma (BBIO) stake by 0.76% in Q2 2026, selling an estimated $420 and leaving 781 shares worth $58.2K. The position accounts for 0.01% of the portfolio, ranked #1167.

Pinnacle Wealth Planning Services first reported a position in BBIO in Q4 2020 and has held it in 4 quarters since. The position peaked at $60.2K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Pinnacle Wealth Planning Services held 781 shares of BridgeBio Pharma worth $58.2K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 6 BridgeBio Pharma shares in Q2 2026, an estimated $420.
  • BridgeBio Pharma made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1167 holding.
  • Pinnacle Wealth Planning Services first reported a position in BridgeBio Pharma in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's BridgeBio Pharma position peaked at $60.2K in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.